KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells

Development of chemoresistance remains a major hurdle for triple negative breast cancer treatment. Previous studies suggest that CD44+/CD24- cells, subpopulation of cancer stem cells with self-renewing and tumor-initiating capacities, are partly responsible for chemoresistance and therapeutic failur...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Jiang, Meng, Zhuang, Huiru, Xia, Rui, Gan, Lei, Wu, Yuantao, Ma, Junzhe, Sun, Yihui, Zhuang, Zhixiang
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2017
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696167/
https://ncbi.nlm.nih.gov/pubmed/29190901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20785
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires